유전체 맞춤의학 연구와 위험의 개념 이해

• 영문명: The Concept of Risk in the era of Personalized Genetic Medicine
• 발행기관: 이화여자대학교 생명의료법연구소
• 저자명: 이일학(Lee. Ilhak) 김성혜(Kim. Sung-Hae) 유승협(Yoo. Seung Hyup) 김소윤(Kim, So Yoon)
• 간행물 정보: 『생명윤리정책연구(제 9권 제 3호 이전)』제6권 제2호, 23~40쪽, 전체 18쪽
• 주제분류: 법학 > 법학
• 파일형태: PDF
• 발행일자: 2012.12.30

영문 초록

Personalized genetic medicine(PGM) is an attempt to understand the relationship between human genetic information and diseases, and to find a potential treatment and diagnostic method. Large research projects are under way with social concerns. ELSI research is aimed at understanding the implication of an innovative research from humanistic perspectives, and communicating the understanding with society and with scientists, thereby providing practical and concrete recommendations and guides. Of the ELSI studies, ethics of PGM research searches the value problems embedded in various perspectives on PGM and tries to answer the question whether it is permissible to implement certain types of research. A framework for ethical analysis is proposed and explained. The concept of risk in general was explored and its implication for ethical review of PGM in relation with the natures of PGM was given. The risks can be categorized: risks associated with the inherent characteristics of research/practice, risks associated with human eras and risks related social construction and (in)justice. Understanding the nature of risk will help the IRB’s reviewing the PGM researches.

목차

Ⅰ. 서론: 유전자의 시대

Ⅱ. 유전체 맞춤의학에 대한 윤리적 규율

Ⅲ. ELSI 연구에서 윤리적 분석의 프레임워크

Ⅳ. 윤리적 평가 근거로서 위험과 이익

Ⅴ. 마치는 말

키워드

ELSI 유전체 맞춤의학 윤리적 규율 위험 ELSI personalized genomic medicine ethical framework risk